Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: MELANOMA (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Érica Aparecida de et al. The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 out. 2024. , 2015APA
Oliveira, É. A. de, Souza, G. F. de, Suárez, J. A. Q., & Maria-Engler, S. S. (2015). The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Oliveira ÉA de, Souza GF de, Suárez JAQ, Maria-Engler SS. The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 4 res. FCF003.[citado 2024 out. 01 ]Vancouver
Oliveira ÉA de, Souza GF de, Suárez JAQ, Maria-Engler SS. The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 4 res. FCF003.[citado 2024 out. 01 ]